| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |